Albenza

Albenza is a brand name of albendazole, approved by the FDA in the following formulation(s):

ALBENZA (albendazole - tablet; oral)

• 
  Manufacturer: COREPHARMA
  
  Approval date: June 11, 1996
  
  Strength(s): 200MG ^[RLD]

Has a generic version of Albenza been approved?

No. There is currently no therapeutically equivalent version of Albenza available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Albenza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Albenza.

See also...

• Albenza Consumer Information (Wolters Kluwer)
• Albenza Consumer Information (Cerner Multum)
• Albenza Advanced Consumer Information (Micromedex)
• Albenza AHFS DI Monographs (ASHP)
• Albendazole Consumer Information (Wolters Kluwer)
• Albendazole Consumer Information (Cerner Multum)
• Albendazole Advanced Consumer Information (Micromedex)
• Albendazole AHFS DI Monographs (ASHP)